Tech Company Financing Transactions
Anthera Pharmaceuticals Funding Round
On 9/13/2006, Anthera Pharmaceuticals raised $36 million in Series A funding from Mitsubishi Corporation, Pappas Ventures and Sofinnova Ventures.
Transaction Overview
Company Name
Announced On
9/13/2006
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series A
Investors
Sofinnova Ventures (James Healy)
VantagePoint Capital Partners (Annette Bianchi)
Proceeds Purpose
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
700 Milam 1300
Houston, TX 77002
USA
Houston, TX 77002
USA
Phone
Undisclosed
Website
Email Address
Overview
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Truex
Browse more venture capital transactions:
Prev: 9/13/2006: NuPathe venture capital transaction
Next: 9/13/2006: Signiant venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs